Phakia and Prior Incisional Surgery Impact MicroPulse Transscleral Laser Therapy for Glaucoma Outcomes: A Retrospective Cohort Study.

Q3 Medicine
Journal of Current Glaucoma Practice Pub Date : 2024-10-01 Epub Date: 2025-01-20 DOI:10.5005/jp-journals-10078-1458
Skyler G Jones, Forrest Clark, Marc Toeteberg-Harms
{"title":"Phakia and Prior Incisional Surgery Impact MicroPulse Transscleral Laser Therapy for Glaucoma Outcomes: A Retrospective Cohort Study.","authors":"Skyler G Jones, Forrest Clark, Marc Toeteberg-Harms","doi":"10.5005/jp-journals-10078-1458","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess (1) safety and efficacy of MicroPulse transscleral laser therapy (TLT) for primary open-angle glaucoma (POAG) and (2) the influence of prior incisional glaucoma surgery, lens status, and visual acuity on TLT outcomes.</p><p><strong>Setting: </strong>Institutional.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Materials and methods: </strong>Study population: Included were POAG patients aged 18-85 with TLT between 1st January 2020 and 15th July 2023; excluded were patients with secondary glaucomas, inflammatory disease, or pregnancy.Intervention: MicroPulse TLT was performed on one or both eyes with an Iridex Cyclo G6 Laser with settings: 31.3% duty cycle, 2,500 mW, 20 second/sweep/hemisphere, four to six sweeps. The revised MP3 probe was used.Outcome measures: Pre- and postop: intraocular pressure (IOP), best-corrected visual acuity (BCVA), glaucoma meds, subsequent procedures, cystoid macular edema (CME).Analysis: Kaplan-Meier (KM) survival statistics starting one month postop with dropout parameters: hypotony, subsequent glaucoma procedure, glaucoma medications >baseline, IOP >21 mm Hg, IOP reduction <20%, or loss of LP vision.</p><p><strong>Results: </strong>Thirty-three eyes were included. Mean KM survival (months) was: all eyes 8.4 ± 1.1; phakia 6.2 ± 0.8; pseudophakia 10.8 ± 2.4; aphakia 9.2 ± 1.8; prior tube shunt 10.2 ± 1.8; no filtration 6.8 ± 0.8. IOP and glaucoma medications remained at or below baseline at all postoperative timepoints. There were no significant changes in BCVA for patients with good baseline vision (>20/40), and no patients developed hypotony, persistent inflammation, or lost LP vision. Factors limiting success were time from the procedure and number of sweeps.</p><p><strong>Conclusion: </strong>Survival was better in pseudophakic eyes and after tube shunt surgery. Six sweeps resulted in higher success compared to four. There were no significant cases of postop CME. The procedure did not negatively impact vision in eyes with good baseline vision.</p><p><strong>How to cite this article: </strong>Jones SG, Clark F, Toeteberg-Harms M. Phakia and Prior Incisional Surgery Impact MicroPulse Transscleral Laser Therapy for Glaucoma Outcomes: A Retrospective Cohort Study. J Curr Glaucoma Pract 2024;18(4):142-146.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"18 4","pages":"142-146"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11915355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess (1) safety and efficacy of MicroPulse transscleral laser therapy (TLT) for primary open-angle glaucoma (POAG) and (2) the influence of prior incisional glaucoma surgery, lens status, and visual acuity on TLT outcomes.

Setting: Institutional.

Design: Retrospective cohort study.

Materials and methods: Study population: Included were POAG patients aged 18-85 with TLT between 1st January 2020 and 15th July 2023; excluded were patients with secondary glaucomas, inflammatory disease, or pregnancy.Intervention: MicroPulse TLT was performed on one or both eyes with an Iridex Cyclo G6 Laser with settings: 31.3% duty cycle, 2,500 mW, 20 second/sweep/hemisphere, four to six sweeps. The revised MP3 probe was used.Outcome measures: Pre- and postop: intraocular pressure (IOP), best-corrected visual acuity (BCVA), glaucoma meds, subsequent procedures, cystoid macular edema (CME).Analysis: Kaplan-Meier (KM) survival statistics starting one month postop with dropout parameters: hypotony, subsequent glaucoma procedure, glaucoma medications >baseline, IOP >21 mm Hg, IOP reduction <20%, or loss of LP vision.

Results: Thirty-three eyes were included. Mean KM survival (months) was: all eyes 8.4 ± 1.1; phakia 6.2 ± 0.8; pseudophakia 10.8 ± 2.4; aphakia 9.2 ± 1.8; prior tube shunt 10.2 ± 1.8; no filtration 6.8 ± 0.8. IOP and glaucoma medications remained at or below baseline at all postoperative timepoints. There were no significant changes in BCVA for patients with good baseline vision (>20/40), and no patients developed hypotony, persistent inflammation, or lost LP vision. Factors limiting success were time from the procedure and number of sweeps.

Conclusion: Survival was better in pseudophakic eyes and after tube shunt surgery. Six sweeps resulted in higher success compared to four. There were no significant cases of postop CME. The procedure did not negatively impact vision in eyes with good baseline vision.

How to cite this article: Jones SG, Clark F, Toeteberg-Harms M. Phakia and Prior Incisional Surgery Impact MicroPulse Transscleral Laser Therapy for Glaucoma Outcomes: A Retrospective Cohort Study. J Curr Glaucoma Pract 2024;18(4):142-146.

Phakia和先前的切口手术影响微脉冲经巩膜激光治疗青光眼的结果:一项回顾性队列研究。
目的:评估(1)微脉冲经巩膜激光治疗原发性开角型青光眼(POAG)的安全性和有效性;(2)既往切口青光眼手术、晶状体状态和视力对TLT结果的影响。设置:机构。设计:回顾性队列研究。材料和方法:研究人群:纳入2020年1月1日至2023年7月15日期间接受TLT治疗的18-85岁POAG患者;排除继发性青光眼、炎症性疾病或妊娠的患者。干预:使用Iridex Cyclo G6激光器对一只或两只眼睛进行微脉冲TLT,设置:31.3%占空比,2500 mW, 20秒/扫描/半球,4至6次扫描。使用改良后的MP3探针。结果指标:术前和术后:眼压(IOP)、最佳矫正视力(BCVA)、青光眼药物、后续手术、囊样黄斑水肿(CME)。分析:Kaplan-Meier (KM)术后1个月开始的生存统计数据,退出参数:低眼压,随后的青光眼手术,青光眼药物基线>,IOP >21 mm Hg, IOP降低结果:33只眼睛被纳入。KM平均生存期(月):全眼8.4±1.1;Phakia 6.2±0.8;假性角膜10.8±2.4;晶状体9.2±1.8;前置管分流10.2±1.8;无过滤6.8±0.8。术后所有时间点IOP和青光眼药物均维持在或低于基线水平。基线视力良好(bbb20 /40)的患者BCVA没有显著变化,没有患者出现低视、持续性炎症或LP视力丧失。限制成功的因素是手术时间和扫井次数。结论:假性晶状眼术后及分流术后患者的生存率较高。6次扫井的成功率高于4次。没有明显的术后CME病例。该手术对基线视力良好的眼睛的视力没有负面影响。Jones SG, Clark F, Toeteberg-Harms M. Phakia和既往切口手术对经巩膜激光治疗青光眼预后的影响:一项回顾性队列研究。中华青光眼杂志;2009;18(4):142-146。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Current Glaucoma Practice
Journal of Current Glaucoma Practice Medicine-Ophthalmology
CiteScore
1.00
自引率
0.00%
发文量
38
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信